Study the changes in clinical and in blood cell indices after hydroxyurea treatment for chronic myelo-granulocytic leukemia
- Author:
Thanh Ha Nguyen
- Publication Type:Journal Article
- Keywords:
leukemia
- MeSH:
Leukemia;
Hydroxyurea;
therapeutics;
blood;
diagnosis
- From:Journal of Practical Medicine
2002;435(11):6-8
- CountryViet Nam
- Language:Vietnamese
-
Abstract:
Chronic myelogenous leukemia (CML) is a clonal myeloproliferative disorder of the primitive hematopoietic stem cell. The research is performed to examine the effectiveness of hydroxyurea in treating patients with CML in chronic stage. The results showed that hydroxyurea dramatically improved clinical and hematological condition. All patients reached complete or partial remission
